DXCM Deadline Approaching on October 21, 2024: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Class Action Lawsuit Deadline

Core Viewpoint - A securities class action lawsuit has been filed against DexCom, Inc. for allegedly making materially false and misleading statements regarding its business operations and growth prospects during the specified Class Period from January 8, 2024, to July 25, 2024 [1][2]. Group 1: Allegations - The complaint claims that DexCom's communications about growth and anticipated margins were overly optimistic due to reliance on attracting new customers [2] - It is alleged that DexCom was struggling to maintain successful existing distribution channels [2] - As a result, statements made by the defendants regarding the company's business, operations, and prospects were materially false and misleading, lacking a reasonable basis [2] Group 2: Lead Plaintiff Process - Investors in DexCom have until October 21, 2024, to seek appointment as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel [3] - A lead plaintiff acts on behalf of all class members in directing the litigation and is typically the investor or small group of investors with the largest financial interest [3] - The decision to serve as a lead plaintiff does not affect the ability to share in any recovery [3] Group 3: About the Law Firm - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions in state and federal courts and has a reputation for recovering billions for victims of fraud and corporate misconduct [4] - The firm aims to protect investors, consumers, employees, and others from fraud and negligence by businesses [4]